Physician profile
David Welch
NPI 1871597278
$2,974.65
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,309 · 2020: $826 · 2021: $815 · 2023: $24.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $953.11 | 2019-2021 | |
| Abbvie INC. | $698.20 | 2019-2021 | |
| Pfizer INC. | $308.53 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $302.44 | 2019-2021 | |
| Janssen Biotech, INC. | $156.40 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $150.11 | 2020-2021 | |
| Braintree Laboratories, INC. | $103.92 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $56.82 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $45.41 | 2019-2021 | |
| Daiichi Sankyo INC. | $39.43 | 2019-2020 | |
| Gilead Sciences, INC. | $29.07 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $24.88 | 2023 | Xarelto |
| Qol Medical, LLC | $16.17 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.58 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.25 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $12.86 | 2019 | |
| Shionogi INC | $12.29 | 2020 | |
| Redhill Biopharma INC. | $12.16 | 2020 | |
| Boston Scientific Corporation | $12.11 | 2020 | |
| Ucb, INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.